A5048954401- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Inhalation and Respiratory Drug Delivery
- Biopolymer Synthesis and Applications
- Immune Response and Inflammation
- Chemistry and Chemical Engineering
- Advanced Chemical Sensor Technologies
- Chemical Reactions and Isotopes
- Brucella: diagnosis, epidemiology, treatment
- Liver Diseases and Immunity
- Cardiac Imaging and Diagnostics
- IgG4-Related and Inflammatory Diseases
- Archaeology and Historical Studies
- Immune responses and vaccinations
- Infant Nutrition and Health
- Medical Device Sterilization and Disinfection
- Cancer Treatment and Pharmacology
- Chronic Lymphocytic Leukemia Research
- Cardiac tumors and thrombi
- Marine and environmental studies
- Vaccine Coverage and Hesitancy
- Renal Transplantation Outcomes and Treatments
- Cardiovascular and Diving-Related Complications
- Salmonella and Campylobacter epidemiology
- Blood transfusion and management
Health and Safety Authority
2024
Health Information and Quality Authority
2024
University of Bari Aldo Moro
2024
Hospital Quirón Teknon
2020-2021
Red de Investigación Cardiovascular
2020
Serimmune (United States)
1992
Ospedale Pediatrico Giovanni XXIII
1991
Immunocompromised patients show an impaired vaccine response and remain at high risk of severe COVID-19, despite vaccination. Neutralizing monoclonal antibodies against acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed for prophylaxis treatment. The combination tixagevimab/cilgavimab (AZD7442) has authorized emergency use as pre-exposure but data on safety efficacy in kidney transplant recipients during the Omicron period are limited.
Abstract Background Respiratory syncytial virus (RSV) can cause severe acute respiratory tract infection in infants and older adults. However, until recently, no immunisation interventions were available to reduce the burden of RSV disease general population. New health technologies have now been authorised Europe for (a long-acting monoclonal antibody (nirsevimab) a maternal vaccine (RSVpreF)), two vaccines adults aged ≥60 years (RSVPreF3 RSVpreF). A rapid technology assessment (HTA) was...
A new 4-antigen recombinant immunoblot assay (4-RIBA) for confirmation of hepatitis C virus (HCV) C-100 enzyme-linked immunosorbent (ELISA) reactivity was tested in serum samples 11 pediatric patients on dialysis. Of 6 HCV ELISA-positive samples, all were 4-RIBA positive. The 2nd generation ELISA picked up 1 additional case confirmed by 4-RIBA. tests increased the prevalence HCV-positive cases.
Abstract Background Atrial morphological parameters may influence the presence of atrial thrombus, a factor strongly associated with cardiac thromboembolism, independently those included in CHA2DS2-VASc risk estimation scale patients history fibrillation (AF). The aim our study was to evaluate this possible association by transthoracic echocardiography (TTE). Methods Prospective multicenter including 401 AF, which TTE and transesophageal echocardiogram (TEE) were performed for evaluation...
Abstract Funding Acknowledgements Dr Teres was funded by Swiss Heartrhythm Foundation Introduction Circumferential pulmonary vein isolation (PVI) has become a mainstay in the treatment of atrial fibrillation (AF). The utility ablation index (AI) to dose radiofrequency delivery for reduction AF recurrences already been proven with target AI ≥ 400 at posterior wall and ≥550 anterior Wall. Nevertheless, left is thin, heterogeneous structure an important inter intra-patient variability LAWT....
Abstract Funding Acknowledgements Dr Teres was funded by Swiss Heartrhythm Foundation Introduction pulmonary vein (PV) reconnections due to gaps on circumferential ablation lines are responsible for atrial fibrillation recurrences after catheter ablation. We sought analyze the local left wall thickness (LAWT) of PV line at AF redo during real-time positioning. LAWT measured MDCT 3D reconstruction and fused with LA anatomy using CARTO-merge. Objective To relationship between reconnection...
Abstract Funding Acknowledgements Type of funding sources: Private grant(s) and/or Sponsorship. Main source(s): Dr Teres is funded by the research fellowship grant from Swiss Heart Rhythm Foundation, Carreno was a Scholarship Sociedad Española de Cardiología (SEC). Introduction Left atrial wall thickness (LAWT) determinant transmural lesion formation during fibrillation (AF) ablation. The utility ablation index (AI) to dose radiofrequency (RF) delivery for reduction AF recurrences has...
Abstract Funding Acknowledgements Type of funding sources: Private grant(s) and/or Sponsorship. Main source(s): Dr Teres was funded by the research fellowship grant Swiss Heart Rhythm Foundation. Carreno-Lineros a Scholarship from Sociedad Española de Cardiología (SEC). Introduction pulmonary vein isolation (PVI) approach implies unavoidable ablation on posterior atrial wall which is closely related to esophagus. PVI may result in several complications. Objective present study aims analyze...